Clinical Study for Development of Oral Galactose Single Point (OGSP) Solution (G.S.P. Oral Solution®)
Status:
Unknown status
Trial end date:
2018-03-31
Target enrollment:
Participant gender:
Summary
The primary objective is to determine the oral galactose single point (OGSP) cutoff values to
discriminate subjects with different hepatic function. The secondary objective is to analyze
the correlations between OGSP and other hepatic function assessment methods among this trial
subjects.